This article has Open Peer Review reports available.
Occipital lobe seizures and subcortical T2 and T2* hypointensity associated with nonketotic hyperglycemia: a case report
© The Author(s). 2016
Received: 23 February 2016
Accepted: 13 July 2016
Published: 12 August 2016
Nonketotic hyperglycemia often causes seizures. Recently, seizures associated with nonketotic hyperglycemia have been found to be associated with subcortical T2 hypointensity on magnetic resonance imaging, especially in the occipital lobes. However, the mechanism remains unclear, although iron accumulation is suggested. We present a case of occipital lobe seizures associated with nonketotic hyperglycemia supporting the hypothesis that the mechanism of subcortical T2 hypointensity is iron accumulation using gradient-echo T2*-weighted magnetic resonance imaging.
A 65-year-old Japanese man complained of intermittent pastel-colored flashing lights. On neurological examination, he also had lower right-side quadrant hemianopia. No other abnormal neurological findings were found. On laboratory analysis, his blood glucose level was 370 mg/dL, HbA1c was 11.4 %, and serum osmolarity was 326 mOsm/L. No ketones were detected in urine. A magnetic resonance imaging scan of his head showed subcortical T2 and T2* hypointensity in his left occipital lobe. Single-photon emission computed tomography with I123-N-isopropyl-iodoamphetamine revealed hyperperfusion in the left dominant occipital lobe. These magnetic resonance imaging abnormalities resolved during clinical recovery and treatment to control his blood sugar level. Therefore, a diagnosis of occipital lobe seizures associated with nonketotic hyperglycemia was made.
To the best of our knowledge, this is the first case of occipital lobe seizures associated with nonketotic hyperglycemia supporting the role of iron accumulation as a mechanism for subcortical T2 hypointensity using T2*-magnetic resonance imaging.
Nonketotic hyperglycemia (NKH) is a clinical syndrome comprising hyperglycemia, serum hyperosmolality, and intracellular dehydration with little or no ketoacidosis. NKH has been associated with various neurological manifestations. Several cases of subcortical T2 hypointensity after seizures associated with NKH have been reported [1, 2]. Although iron accumulation as a result of damage to axonal transport is suggested, the mechanism remains unclear. Here, we describe the case of a 65-year-old man with subcortical T2 hypointensity in the occipital lobe after seizures associated with NKH. Our case supports the hypothesis that the mechanism of subcortical T2 hypointensity is iron accumulation, because gradient-echo T2*-weighted magnetic resonance imaging (T2*-MRI) also revealed hypointensity in the same region.
A 65-year-old Japanese man who had a past medical history of chronic obstructive pulmonary disease and no remarkable family medical history reported seeing intermittent pastel-colored flashing lights in his lower right-side visual field. Two weeks later, the flashing lights increased in frequency and appeared every 15–30 minutes for approximately 3 minutes at each occurrence. Consequently, the patient visited our hospital.
Consequently, we initially diagnosed NKH, although he had not been diagnosed with diabetes mellitus (DM), and considered that occipital lobe seizures were associated with NKH. Subsequently, we started intensive insulin therapy, vildagliptin (100 mg/day), and rehydration to control blood sugar. As his blood glucose became stable, his intermittent pastel-colored flashing lights lessened and disappeared 3 days after initiation of treatment. His quadrant hemianopia gradually improved, and completely resolved 2 weeks after treatment. A follow-up brain MRI scan, performed 75 days after the first MRI, showed disappearance of subcortical T2 and T2* hypointensity, and DWI cortical hyperintensity (Fig. 1f–h). His HbA1c improved to 6.6 % 3 months after initiation of treatment, and was stable for more than 2 years under treatment of vildagliptin (100 mg/day) and metformin (750 mg/day). He had no recurrence of intermittent pastel-colored flashing lights and quadrant hemianopsia for more than 2 years.
NKH is a serious acute complication of DM, typically in patients over 50 years with type 2 DM, and a clinical syndrome comprising severe hyperglycemia, hyperosmolarity, and intracellular dehydration occurring with little or no ketoacidosis. NKH has been associated with various neurological manifestations such as delirium, seizures, hemichorea-hemiballism, dysphagia, hemianopia, hemiparesis, and hemisensory loss. Most seizures associated with NKH are partial seizures with or without secondary generalization, which are refractory to antiepileptic drugs. Optimal treatment is correction of fluid and electrolyte abnormalities, and glycemic control. Particularly, the occipital lobe is potentially the most affected area, and occipital lobe seizures associated with NKH can cause flashing lights, well-formed visual hallucinations, photopsias, headache, vomiting, gaze and head deviation, blurry vision, and homonymous hemianopia. Seizures associated with NKH occasionally accompany characteristic MRI abnormalities, comprising subcortical T2 hypointensity in the white matter, hyperintensity of the overlying cortex, and focal overlying cortical contrast enhancement, reversible with the course of clinical recovery [1–3]. Despite markedly elevated HbA1c, the majority of cases, as well as our case, have only moderate hyperglycemia and absence of significant hyperosmolarity, and do not fulfill the diagnostic criteria for hyperosmolar hyperglycemic syndrome (HHS) (plasma glucose level of 600 mg/dL or greater, serum osmolality of 320 mOsm/kg or greater, profound dehydration, serum pH > 7.30, bicarbonate concentration > 15 mEq/L, small ketonuria, and absent-to-low ketonemia, and alterations in consciousness ). This suggests that long-standing hyperglycemia likely causes seizures rather than acute-onset extreme hyperglycemia .
Given hypointensity on T2-MRI and T2*-MRI, and occipital lobe lesion, we investigated possible microhemorrhage or posterior reversible encephalopathy syndrome (PRES). However, hypointensity on T2*-MRI in our case was not spotty, and the boundary was unclear. Blood pressure was not high, and PRES generally presents with T2 hyperintensity and does not present with subcortical T2 hypointensity. Therefore, we confirmed the diagnosis of occipital lobe seizure associated with NKH.
Despite increasing reports of similar cases, the detailed mechanism of T2 hypointensity remains uncertain. Neurons cannot exist without iron, which is an essential cofactor for enzymes involved with energy metabolism and synthesis of neurotransmitters. It is impossible to determine in our case and in similar cases whether excess iron caused neuronal cell damage or whether iron homeostasis was disrupted due to hyperglycemia. However, we speculate that accumulation of iron (enough to be reflected in T2-MRI and T2*-MRI) associated with disruption of axonal transportation, due to early cortical ischemia or excitotoxic damage from seizures, are potential mechanisms . In our patient, MRI showed subcortical T2 hypointensity in his left occipital lobe in T2-MRI and T2*-MRI, strongly supporting the hypothesis that iron accumulation can contribute to these changes.
Ischemia or seizures without hyperglycemia can result in similar MRI abnormalities, indicating that subcortical T2 hypointensity is not specific to seizures associated with NKH . However, many cases of seizure associated with NKH have been reported. Speculatively, cortical damage can be sufficient to lead to iron accumulation, and hyperglycemia can only result in acceleration of this pathophysiology. In contrast, many similar reported cases, as well as our case, are Asian. Thus, genetic or environmental factors may contribute to this pathophysiology.
To the best of our knowledge, this is the first case of occipital lobe seizures associated with NKH supporting the role of iron accumulation as a mechanism for subcortical T2 hypointensity using T2*-MRI. However, the precise mechanism of iron accumulation remains uncertain. Further investigations are needed to reach verifiable conclusions.
DM, diabetes mellitus; DWI, diffusion-weighted imaging; EEG, electroencephalography; HHS, hyperosmolar hyperglycemic syndrome; IMP-SPECT, single-photon emission computed tomography with I123-N-isopropyl-iodoamphetamine; MRI, magnetic resonance imaging; NKH, nonketotic hyperglycemia; PRES, posterior reversible encephalopathy syndrome; T2*-MRI, gradient-echo T2*-weighted magnetic resonance imaging; T2-MRI, gradient-echo T2-weighted magnetic resonance imaging
We thank Dr. Kotaro Ogaki and Dr. Chitose Shiozawa for her assistance in drafting the manuscript.
The authors report no sources of funding.
Availability of data and materials
The dataset supporting the conclusions of this article is available in the repository.
FS, SK, SN, AY, YT, KN, and YO cared for the patient in both the in-patient and out-patient settings. NH reviewed the manuscript and provided suggestions. All the authors contributed to the writing of the manuscript and read and approved the final version of the manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Raghavendra S, Ashalatha R, Thomas SV, Kesavadas C. Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with a nonketotic hyperglycemic hyperosmolar state. Neuroradiology. 2007;49:299–305.View ArticlePubMedGoogle Scholar
- Seo DW, Na DG, Na DL, Moon SY, Hong SB. Subcortical hypointensity in partial status epilepticus associated with nonketotic hyperglycemia. J Neuroimaging. 2003;13:259–63.View ArticlePubMedGoogle Scholar
- Hung WL, Hsieh PF, Lee YC, Chang MH. Occipital lobe seizures related to marked elevation of hemoglobin A1C: report of two cases. Seizure. 2010;19:359–62.View ArticlePubMedGoogle Scholar
- Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29:2739–48.View ArticlePubMedGoogle Scholar
- Cerase A, Leonini S, Franceschini R, Grosso S, Venturi C. Subcortical low-intensity and restricted diffusion after first seizure in a child. J Comput Assist Tomogr. 2011;35:501–3.View ArticlePubMedGoogle Scholar